Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell…

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,663 followers.

RT @FrontOncology: New research: Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chem…

21 Nov 2023

Reply Repost Favourite

New research: Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation: Background The use of… https://t.c

21 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.